Narrativas da transição: um olhar sobre a transferência de poderes de Macau vista pelo jornal Ponto Final: 1996-2001

Dissertação apresentada à Escola Superior de Comunicação Social como parte dos requisitos para obtenção de grau de mestre em Jornalismo.

Relatório final de estágio no gabinete de engenharia termodinamica ACET

Trabalho Final de Mestrado para obtenção do grau de Mestre em Engenharia Mecânica com Especialização em Energia, Climatização e Refrigeração

Trabalho final de estágio no âmbito da reabilitação de edifícios de serviços do Ministério da Saúde

Relatório de Estágio para obtenção do grau de Mestre em Engenharia Civil

A lei de bases da economia social portuguesa: do projeto ao texto final

ISSN 1577-4430, com fator de impacto, calculado pelo IN-RECS (http://ec3.ugr.es/in-recj/ii/Derecho_Civil-2010.htm), Bases de dados de indexação: LATINDEX, DIALNET, ISOC, COMLUDOC e AGRIS]

Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00).

BACKGROUND: The aim of this study was to evaluate the efficacy and tolerability of fulvestrant, an estrogen receptor antagonist, in postmenopausal women with hormone-responsive tumors progressing after aromatase inhibitor (AI) treatment. PATIENTS AND METHODS: This is a phase II, open, multicenter, noncomparative study. Two patient groups were prospectively considered: group A (n=70) with AI-responsive disease and group B (n=20) with AI-resistant disease. Fulvestrant 250 mg was administered as intramuscular injection every 28 (+/-3) days. RESULTS: All patients were pretreated with AI and 84% also with tamoxifen or toremifene; 67% had bone metastases and 45% liver metastases. Fulvestrant administration was well tolerated and yielded a clinical benefit (CB; defined as objective response or stable disease [SD] for >or=24 weeks) in 28% (90% confidence interval [CI] 19% to 39%) of patients in group A and 37% (90% CI 19% to 58%) of patients in group B. Median time to progression (TTP) was 3.6 (95% CI 3.0 to 4.8) months in group A and 3.4 (95% CI 2.5 to 6.7) months in group B. CONCLUSIONS: Overall, 30% of patients who had progressed following prior AI treatment gained CB with fulvestrant, thereby delaying indication to start chemotherapy. Prior response to an AI did not appear to be predictive for benefit with fulvestrant.

Evaluation of Bond Retainage in Portland Cement Concrete Overlays Using Infrared Thermography and Ground Penetrating Radar, HR-537, Final Report, 1989

When concrete deterioration begins to occur in highway pavement, repairs become necessary to assure the rider safety, extend its useful life and restore its riding qualities. One rehabilitation technique used to restore the pavement to acceptable highway standards is to apply a thin portland cement concrete (PCC) overlay to the existing pavement. First, any necessary repairs are made to the existing pavement, the surface is then prepared, and the PCC overlay is applied. Brice Petrides-Donohue, Inc. (Donohue) was retained by the Iowa Department of Transportation (IDOT) to evaluate the present condition with respect to debonding of the PCC overlay at fifteen sites on Interstate 80 and State Highway 141 throughout the State of Iowa. This was accomplished by conducting an infrared thermographic and ground penetrating radar survey of these sites which were selected by the Iowa Department of Transportation. The fifteen selected sites were all two lanes wide and one-tenth of a mile long, for a total of three lane miles or 190,080 square feet. The selected sites are as follows: On Interstate 80 Eastbound, from milepost 35.25 to 35.35, milepost 36.00 to 36.10, milepost 37.00 to 37.10, milepost 38.00 to 38.10 and milepost 39.00 to 39.10, on State Highway 141 from milepost 134.00 to 134.10, milepost 134.90 to milepost 135.00, milepost 135.90 to 136.00, milepost 137.00 to 137.10 and milepost 138.00 to 138.10, and on Interstate 80 Westbound from milepost 184.00 to 184.10, milepost 185.00 to 185.10, milepost 186.00 to 186.10, milepost 187.00 to 187.10, and from milepost 188.00 to 188.10.

[17]: Mamelles 1er acte [Les Mamelles de Tirésias, Paris] ; [18]: Mamelles (Paris) - Final acte I

Ancien possesseur : Poulenc, Francis (1899-1963)

Informe final: Medición de la satisfacción de la renovación de la matricula mercantil del año 2012 - Sede Norte

Banco del conocimiento

Informe final: Medición de la satisfacción de la renovación de la matricula mercantil del año 2012 - Sede Poloquemao

Banco del conocimiento

Informe final consolidado: Medición de la satisfacción y lealtad con el servicio de renovación de la Matrícula Mercantil de la CCB del 2012- Canal presencial (sedes)

Banco del conocimiento

Informe final: Medición de la satisfacción de la renovación de la matricula mercantil del año 2012 - Sede Sede Restrepo

Banco del conocimiento

Informe final de investigación

Banco del conocimiento

Informe final: Medición de la satisfacción de la renovación de la matricula mercantil del año 2012 - Sede Sede Salitre

Banco del conocimiento

Informe final: Medición de la satisfacción de la renovación de la matricula mercantil del año 2012 - Sede Sede Zipaquira

Banco del conocimiento

Informe final: Medición de la satisfacción de la renovación de la matricula mercantil del año 2012 - Sede Centro

Banco del conocimiento